News & Analysis on Clinical Trial Services & Contract Research And Development
Sinobiopharma is seeking a Chinese patent covering the manufacture of capsule forms of the heart drug perindopril, claiming it is the first company in the world to produce the medication in this easy to swallow format.
PPD’s revenues dipped in Q1 as the company was hit by contract cancellations totaling $215m (€166m), which included a $77m deal with a large biotech for a multinational clinical trial.
IntelGenx’ clinical pilot study indicates the bioequivalence of a leading antihypertensive and its product, which has been developed using its multilayer Versatab delivery technology.
US firm Kendle is the latest CRO to revise its forecast and blame “unprecedented biopharmaceutical industry conditions,” which are fast becoming an industry catchphrase, for its Q1 woes.
in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical industry, including movement at Pfizer, Solvay and Biovail.